|
Trial Name |
Description of Trial |
|
TIMI-14A |
Open-label angiographic trial evaluating the benefit of ReoPro™ Bolus plus 12-hour infusion alone or in conjunction with thrombolytic therapy for acute myocardial infarction. |
| TRA-2P TIMI 50 | SCH 530348 in addition to standard of care in subjects with a history of atherosclerotic disease: thrombin receptor antagonist in secondary prevention. |
|
TRUST 1 |
A registry of a-SIC-H coated Tenax Stent in patients with stable angina pectoris. |
|
TRUST 2 |
A randomized trial of a-SIC-H coated Tenax Stent versus the NIR Stent in patients with acute coronary syndromes. |
| TWILIGHT | Ticagrelor with aspirin or alone in high-risk patients after coronary intervention. |
|
VALIANT |
Active-controlled parallel group study comparing the efficacy and safety of long-term treatment with valsartan, captopril and their combination in high-risk patients after myocardial infarction. |
|
VALSARTAN |
To assess the effect of valsartan on exercise capacity , quality of life, and signs and symptoms, in patients with stable, chronic congestive heart failure (NYHA Class II-IV). |
| VELOCITY |
A pilot study to evaluate ultrafast hypothermia before reperfusion in patients with acute ST-Elevation myocardial infarction. |
| VICTOR | A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction. |
| VISTA 16 | Vascular inflammation suppression to treat ACS for 16 weeks. |
|
X80 |
A pilot evaluation of the procedural outcome of Excimer Laser Angioplasty with the Spectranetics XTO catheters, model numbers 110-002 and 110-004 with increased laser parameter range. |
XIENCE 28 |
A prospective single armed multi-center open label trial (Xience 28 USA – ABT-CIP-10271). Trial is to evaluate safety of 1-month dual antiplatelet therapy in subjects at high risk of bleeding undergoing percutaneous coronary intervention (PCI). |
|
ZESCA |
Zyban (bupropion) as an effective smoking cessation aid for patients following an acute coronary syndrome. |
 |
©Victoria Heart Institute Foundation
"Yesterday's research is tomorrow's best practice... Today's research leads to tomorrow's breakthroughs."